Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Clinical trial NCT06321484 · RECRUITING

Trial details

NCT number: NCT06321484
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Recurrent Ovary Cancer Ovarian Cancer Ovarian Carcinoma Ovarian Carcinoma, Recurrent Endometroid Ovarian Carcinoma Clear Cell Ovarian Carcinoma

Start date: 2024-10-09
Primary completion: 2026-11-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.